Assessing differences in clinical trials comparing surgical vs nonsurgical therapy: Using common (statistical) sense

JAMA

Volumn 278, Issue 17, 1997, Pages 1432-1436

  Howard, George ^a   Chambless, Lloyd E ^b   Kronmal, Richard A ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE; CLINICAL TRIAL; FOLLOW UP; HUMAN; HYPOTHESIS; LIFE EXPECTANCY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; REVIEW; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030712416     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.1997.03550170062033     Document Type: Review

References (16)

1. Bonadonna G, Zambetti M, Valagussa P. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes: ten-year results. JAMA. 1995;273:542-547.
2. Elandt-Johnson RC, Johnson NL. Survival Models and Data Analysis. New York, NY: John Wiley & Sons Inc; 1980.
3. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons Inc; 1980.
4. Flemming TR, Harrington DP. Counting Processes and Survival Analysis. New York, NY: John Wiley & Sons Inc; 1991.
5. Gill RD, Schumacher M. A simple test of the proportional hazards assumption. Biometrika. 1987;74: 289-300.
6. Lee ET, Desu MM, Gehan EA. A Monte-Carlo study of the power of some two-sample tests. Biometrika. 1975;62:425-432.
7. The Asymptomatic Carotid Atherosclerosis Study Group. Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. Stroke. 1989;20:844-849.
8. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995; 273:1421-1428.
9. Principal Investigators of CASS and Their Associates. The National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. Circulation. 1981;63:(suppl 1):I1-I81.
10. CASS Principal Investigators and Their Associates. Myocardial infarction in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med. 1984;310:750-758.
11. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. St Louis, Mo: Mosby-Year Book Inc; 1996.
12. Sacks FM, Pfeffer MA, Moye LE, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
13. Fisher CJ, Slotman GJ, Opal SM, et al. The IL-1RA Sepis Syndrome Study Group, initial evaluation of human recombinant interleukin 1 receptor antagonist in the treatment of sepsis syndrome. Crit Care Med. 1994;22:12-21.
14. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549-556.
15. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70: 659-663.
16. Miller RG Jr. Simultaneous Statistical Inference. 2nd ed. New York, NY: Springer-Verlag NY Inc; 1981.